Announcements Trials

Browse Landscape

Status

Recruiting 26 Active not recruiting 17 Not yet recruiting 10 Completed 2 Terminated 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Pneumonia 1 Lung Diseases, Interstitial 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 28 Carboplatin 18 Cisplatin 15 Nivolumab 13 Pemetrexed 12 Paclitaxel 11 Specimen Handling 10 Ipilimumab 10 Gemcitabine 10 venetoclax 8 durvalumab 8 atezolizumab 8 Radiotherapy 8 Radiosurgery 8 Magnetic Resonance Spectroscopy 8 Docetaxel 7 Cyclophosphamide 7 Biopsy 7 fludarabine 6 enzalutamide 6 Bevacizumab 6 tislelizumab 5 tazemetostat 5 X-Rays 5 Trastuzumab 5 Surveys and Questionnaires 5 Practice Guidelines as Topic 5 Interviews as Topic 5 Injections 5 Dexamethasone 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Observation × 90 days × Clear all

NCT06192004 2026-05-04

LOOP

AstraZeneca

Carcinoma, Non-Small-Cell Lung, Pneumonia, Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡